[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620969":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":26,"collaborators":7,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":50,"overallStatus":10,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Instituto Bernabeu","OTHER",null,[9],{"facility":5,"status":10,"city":11,"state":7,"zip":7,"country":12,"countryCode":13,"cosmosGeoPoint":14,"geoPoint":19,"contacts":20},"RECRUITING","Alicante","Spain","ES",{"type":15,"coordinates":16},"Point",[17,18],-0.48149,38.34517,{"lat":18,"lon":17},[21],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},"BELEN LLEDO, PhD","CONTACT","965154053","blledo@institutobernabeu.com",{"type":27,"investigatorFullName":28,"investigatorTitle":29,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Belen Lledo","Director","100620969","non-invasive-preimplantation-genetic-screening-for-aneuploidies-and-clinical-outcomes-in-egg-donation-patients-100620969",false,"NCT07364526","Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients","Non-invasive Preimplantation Genetic Screening (niPGTA) in Oocyte Donation Patients.","niPGTAdon","Inclusion Criteria:\n\n* Women between 18 and 50 years old who are oocyte recipients.\n* Signed consent form\n* Transfer of a single blastocyst-stage embryo\n* Male with normal sperm FISH\n\nExclusion Criteria:\n\n* Uterine malformations\n* Abnormal karyotypes in either partner\n* Failure to sign informed consent",true,"FEMALE","18 Years","50 Years",{"count":43,"type":44},164,"ESTIMATED","3 Years","OBSERVATIONAL","Preimplantation genetic testing for aneuploidies (PGT-A) is commonly used in IVF but requires embryo biopsy and shows limited benefit in egg donation cycles. Non-invasive PGT-A (niPGTA), based on the analysis of cell-free embryonic DNA in spent culture media, offers a promising biopsy-free alternative. This prospective, blinded study in egg donation cycles will evaluate whether niPGTA-detected aneuploidy is associated with implantation failure and pregnancy loss, assessing its potential clinical value as a non-invasive embryo selection tool.",[49],"IVF",[51],"niPGTA","2026-01-21",{"date":54,"type":55},"2026-01-23","ACTUAL",{"date":57,"type":44},"2026-02-26",{"date":59,"type":44},"2027-12-01",{"name":5,"class":6},1]